Composition: 1 ml of a sterile solution contains: demineralized water 8.5 ± 0.5 mg NaCl; 0.1 ± 0.01 mg of CaCl2 and 10-8-10-9 mg of a protein-peptide complex isolated from retinal pigment epithelial tissue of young bulls.
The physiological effect of Vioftan-4 is associated with its ability to maintain the viability of pigment epithelial cells, their adhesive interactions in the retinal monolayer, to additionally activate cellular sources of regeneration in the retina - Müller glia cells and bipolar cells, and to ensure the spatially functional organization of the inter-photoreceptor space.
Indications for use: traumatic injury, retinal dystrophy, retinitis pigmentosa, the initial stage of macular degeneration of the eye.
Mode of application
Instill 1-2 drops of Vioftan-1 solution in the eye 3-10 times a day, depending on the severity of the eye lesion. Discontinuation of the drug - after the disappearance of negative sensations in the eye, for example, a foreign body sensation, lacrimation, photophobia.
Vioftan-1 is combined with other ophthalmic preparations. The time interval between taking Vioftan 1 and another drug is at least 30 minutes.